You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/11809
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFortaleza, Carlos Magno Castelo Branco-
dc.contributor.authorFigueiredo, Ligia Castellon-
dc.contributor.authorBeraldo, Carolina Contador-
dc.contributor.authorde Melo, Edson Carvalho-
dc.contributor.authorSales Pola, Patricia Maria-
dc.contributor.authorNagem Aragao, Valeria Drummond-
dc.date.accessioned2014-05-20T13:34:27Z-
dc.date.available2014-05-20T13:34:27Z-
dc.date.issued2009-06-01-
dc.identifierhttp://dx.doi.org/10.1590/S1413-86702009000300004-
dc.identifier.citationBrazilian Journal of Infectious Diseases. Salvador: Contexto, v. 13, n. 3, p. 173-176, 2009.-
dc.identifier.issn1413-8670-
dc.identifier.urihttp://hdl.handle.net/11449/11809-
dc.description.abstractOropharyngeal carriage of Pseudomonas aeruginosa is associated with increased risk of infection and may provide a source for spread of drug-resistant strains. In order to assess the incidence and risk factors of oropharyngeal carriage, we conducted a retrospective cohort study based on results of surveillance cultures (oropharyngeal swabs) from a medical-surgical intensive care unit, collected from March 2005 through May 2006. Variables investigated included demographic characteristics, comorbid conditions, invasive procedures, use of devices and use of antimicrobials. Thirty case patients with P. aeruginosa carriage were identified. Other 84 patients with surveillance cultures negative to P. aeruginosa were enrolled as control subjects. Case patients were more likely to have a solid malignancy (Odds Ratio [OR] = 12.04, 95% Confidence Interval [CI] = 1.93-75.09, p=0.008), Acquired Immunodeficiency Syndrome (AIDS, OR = 7.09, 95% CI=1.11-45.39, p = 0.04), central nervous system disease (OR = 4.51, 95% CI = 1.52-13.39, p = 0.007), or to have a central venous catheter placed (OR = 7.76, 95% CI = 1.68-35.79, p=0.009). The use of quinolones was a protective factor (OR = 0.13, 95% CI = 0.03-0.47, p = 0.002). The predominance of comorbidities as risk factors points out a group of patients to whom preventive measures should be directed.en
dc.format.extent173-176-
dc.language.isoeng-
dc.publisherContexto-
dc.sourceWeb of Science-
dc.subjectPseudomonas aeruginosaen
dc.subjectcolonizationen
dc.subjectoropharyngeal carriageen
dc.subjectsurveillance culturesen
dc.subjectintensive care uniten
dc.titleRisk factors of oropharyngeal carriage of Pseudomonas aeruginosa among patients from a Medical-Surgical Intensive Care Uniten
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationState Univ São Paulo, Dept Doencas Tropicais, Botucatu Sch Med, Fac Med Botucatu, BR-18618970 Botucatu, SP, Brazil-
dc.description.affiliationBauru State Hosp, Bauru, SP, Brazil-
dc.description.affiliationUnespState Univ São Paulo, Dept Doencas Tropicais, Botucatu Sch Med, Fac Med Botucatu, BR-18618970 Botucatu, SP, Brazil-
dc.identifier.scieloS1413-86702009000300004-
dc.identifier.wosWOS:000275105600004-
dc.rights.accessRightsAcesso aberto-
dc.identifier.fileS1413-86702009000300004-en.pdf-
dc.relation.ispartofBrazilian Journal of Infectious Diseases-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.